Tricyclic antidepressants exhibit variable pharmacological profiles at the α2A adrenergic receptor |
| |
Authors: | Christopher Cottingham Stefanie Percival Tana Birky Qin Wang |
| |
Institution: | 1. Department of Cell, Molecular and Developmental Biology, University of Alabama at Birmingham, Birmingham, AL 35294, United States;2. Department of Biology and Chemistry, Morehead State University, Morehead, KY 40351, United States |
| |
Abstract: | Antidepressant mechanisms of action remain shrouded in mystery, greatly hindering our ability to develop therapeutics which can fully treat patients suffering from depressive disorders. In an attempt to shed new light on this topic, we have undertaken a series of studies investigating actions of tricyclic antidepressant drugs (TCAs) at the α2A adrenergic receptor (AR), a centrally important receptor, dysregulation of which has been linked to depression. Our previous work established a particular TCA, desipramine, as an arrestin-biased α2AAR ligand driving receptor endocytosis and downregulation but not canonical heterotrimeric G protein-mediated signaling. The present work is aimed at broadening our understanding of how members of the TCA drug class act at the α2AAR, as we have selected the closely related but subtly different TCAs imipramine and amitriptyline for evaluation. Our data demonstrate that these drugs do also function as direct arrestin-biased α2AAR ligands. However, these data reveal differences in receptor affinity and in the extent/nature of arrestin recruitment to and endocytosis of α2AARs. Specifically, amitriptyline exhibits an approximately 14-fold stronger interaction with the receptor, is a weaker driver of arrestin recruitment, and preferentially recruits a different arrestin subtype. Extent of endocytosis is similar for all TCAs studied so far, and occurs in an arrestin-dependent manner, although imipramine uniquely retains a slight ability to drive α2AAR endocytosis in arrestin-null cells. These findings signify an important expansion of our mechanistic understanding of antidepressant pharmacology, and provide useful insights for future medicinal chemistry efforts. |
| |
Keywords: | AMI amitriptyline AR adrenergic receptor Arr arrestin CFP cyan fluorescent protein DMI desipramine ESC escitalopram FLIM fluorescence lifetime imaging microscopy FRET fluorescence resonance energy transfer GPCR G protein-coupled receptor HA hemagglutinin IMI imipramine MEF mouse embryonic fibroblast NE norepinephrine SSRI selective serotonin reuptake inhibitor TCA tricyclic antidepressant YFP yellow fluorescent protein |
本文献已被 ScienceDirect 等数据库收录! |
|